Skip to content

Omega-3 Index

NutrientsMeasured in %

What it measures

The proportion of EPA and DHA in red blood cell membranes, reflecting omega-3 intake over roughly the preceding four months.

Why it matters

It is a more reliable indicator of long-term omega-3 status than dietary recall or a plasma measurement.

Where the claimed ranges actually sit

Measured in %. Each row is one claim about where your result should fall.

What a seller markets as “optimal”
8–12%C8–12 %

Fish oil manufacturers and the laboratories that market the test

View as table
ClaimRangeSource
8–12%8–12 %Fish oil manufacturers and the laboratories that market the test

Where the sources disagree

This entry exists in the registry precisely because it has no conventional range to disagree with. The 'normal' and 'optimal' bands you will see on a consumer dashboard both originate from the same commercial ecosystem. That is worth knowing before you treat a number in the 'low' zone as a deficiency requiring correction.

The marketed ranges, examined

Each claim gets its strongest possible case before it gets its criticism. Several of these are substantially correct.

8–12%

Promoted by fish oil manufacturers and the laboratories that market the test

CConfounded

The strongest case for it

Red cell membrane omega-3 content is a genuine measure of long-term intake, and low levels are associated with higher cardiovascular mortality in observational cohorts.

What it leaves out

The target range was defined by researchers with commercial ties to the test and to supplementation, and large omega-3 supplementation trials have produced mixed and mostly modest results. The 'optimal' zone here is unusually close to being an artifact of the people selling it.

Grade C: Association is real but confounded, assay-dependent, or the intervention trials that would confirm it are null or missing.

Before you act on your result

  • Not a standard clinical test; interpretation frameworks come from commercial sources.
  • Responds slowly: allow at least four months before retesting after a change.
  • Supplementation trial results for cardiovascular outcomes have been mixed.

More in Nutrients

The Mirror Brief

One email when a reference range changes, a panel claim is corrected, or a regulatory status actually moves, not when something is merely proposed. No sponsors from any company we rate.

Unsubscribe anytime. We never sell or share your address.